Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quantifying Brown Adipose Tissue Thermogenesis in Type 2 Diabetes
NCT05092945Completed
- Sponsor
- Université de Sherbrooke
- Start
- May 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of niacin in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Université de Sherbrooke. Primary endpoints: Brown Adipose Tissue volume at 180 minutes and Brown Adipose Tissue Glucose uptake at 150 minutes. Started May 2021; status: completed.
02
Drugs
niacin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT05092945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05092945.